Thermo Fisher Scientific (TMO) Tops Q4 EPS by 1c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% on concerns over AI buildout costs, Fed rate outlook
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil steady as investors focus on Hormuz flows after peace talks
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- BofA lists top 5 themes driving next $1tn in incremental semi sales
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2019 Results
January 30, 2020 6:00 AM ESTWALTHAM, Mass., Jan. 30, 2020 /PRNewswire/ --Â Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2019.
Fourth Quarter and Full Year 2019 Highlights
Fourth quarter revenue increased 5% to $6.83 billion. Fourth quarter GAAP diluted earnings per share (EPS) increased 12% to $2.49. Fourth quarter adjusted EPS increased 9% to $3.55.                                     Full year revenue grew 5% to $25.54 billion. Full year GAAP diluted EPS increased 27% to $9.17. Full year adjusted EPS increased 11% to $12.35.                             Delivered another excellent year of high-impact innovation, launching new products... More